CompoAtlas

FASTACARE - GREEN TEA EXTRACT PLUS L-CARNITINE CAPSULES

Natural health product licensed in Canada

Licence holder
Fastacare Therapeutics Inc.
NPN or DIN-HM
80056005
Status
Inactive licence
Licence date
26 November 2014
Revision date
Not provided
Form
Capsule, dur
Route of administration
Orale
Application type
Non traditionnelle

If this product were sold in France

A daily quantity is calculated only for an explicit adult oral dosage, stated per day and in a solid unit matching the product form. Ambiguous units, liquids, powders and paediatric doses are not extrapolated. A quantity not calculated is not compared with dose limits. This analysis does not constitute authorisation for sale in France or an assessment of safety or efficacy.

Composition

Medicinal ingredient and sourcePer dosage unit, according to the sourceMaximum per day, adult
Camellia sinensis

Source : Camellia sinensis - feuille

Extract : Matériel brut sec

Extraction ratio : 4:1

Dry plant equivalent : 666 mg

Potency : 49.95 mg Epigallocatechin-3-gallate

166.5 mgNot calculated
L-carnitine500 mgNot calculated

Non-medicinal ingredients

Hydroxypropyl methylcellulose

PopulationAgeQuantity per servingFrequency
AdultesNot specified2 Capsule3 Tous les jours

Uses authorised in Canada

Text supplied in English because no French text is available.

Helps support fat metabolism and oxidation. Helps delay fatigue during physical activity. Source of antioxidants for the maintenance of good health. To be used with a program of reduced intake of dietary calories and increased physical activity (if possible) to help in weight management.

A use authorised in Canada is not an authorised health claim in the European Union. See the health claims register.

Warnings in Canada

No French warning text available in the imported data.

Warnings are available in English on the official record.

Source

Official Health Canada record, licence 80056005

Licensed Natural Health Products Database (LNHPD), Health Canada: licensed products, ingredients, doses, uses and risks, retrieved 27 October 2026.

Contains information licensed under the Open Government Licence – Canada (Health Canada, LNHPD)

Licence du gouvernement ouvert – Canada 2.0 (OGL-Canada 2.0)

The formula sold in Europe under the same name may differ. This information does not replace advice from a doctor or pharmacist.

Official warnings (Health Canada)

Health Canada publishes warnings on these ingredients:

  • L-carnitine
    Read the warning, when it applies and the studies cited

    L-CARNITINE

    Route of administration: Oral

    Cautions and warnings

    Ask a health care practitioner/health care provider/health care professional/doctor/physician before use if you are pregnant or breastfeeding (CPS 2008).

    1 study cited in the text has no matching reference in the monograph (see the anomalies listed on the sources page).

    Ask a health care practitioner/health care provider/health care professional/doctor/physician before use if you have a seizure disorder (CPS 2008).

    1 study cited in the text has no matching reference in the monograph (see the anomalies listed on the sources page).

    Health Canada monograph dated 25 July 2025

They concern the ingredient, not this product or its dose. They do not replace medical advice.

The evidence date of this ingredient list is unknown.

Has the product changed? Photograph the packaging.

Is something on this product wrong or out of date, whether you are a reader or the brand? Write to contact@compoatlas.com: every correction is published in the corrections log.

Enter to analyse, Shift+Enter for a new line